Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: Results of supervised learning techniques applied on clinical and inflammatory data

Psychiatry Research

Volumn 200, Issue 2-3, 2012, Pages 754-760

  Maes, Michael ^a   Twisk, Frank N M ^b   Johnson, Cort ^c  

^a Piyavate Hospital   (Thailand)

^b ME de Patiënten Foundation   (Netherlands)

^c Phoenix   (United States)

Author keywords

Chronic fatigue syndrome; Criteria; Diagnosis; Inflammation; Post exertional malaise

Indexed keywords

INTERLEUKIN 1; LYSOZYME; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

12 ITEM FIBROMYALGIA; ADULT; ARTICLE; CHRONIC FATIGUE; CHRONIC FATIGUE SYNDROME; CHRONIC FATIGUE SYNDROME RATING SCALE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FATIGUE; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALAISE; MALE; POST EXERTIONAL MALAISE; PRIORITY JOURNAL; RATING SCALE;

ADULT; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FATIGUE; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1; MALE; MIDDLE AGED; NEOPTERIN; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872370652     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.03.031     Document Type: Article

References (40)

1. Acheson E.D. A new clinical entity?. Lancet 1956, 270(6926):789-790.
2. Acheson E.D. The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia. American Journal of Medicine 1959, 26(4):569-595.
3. Aldenderfer M.S., Blashfield R.K. Validation Techniques. Cluster Analysis 1986, Sage Publications, London, pp. 62-73.
4. Carruthers B.M., Jain A.K., de Meirleir K., Peterson D.L., Klimas N.G., Lerner A.M., Bested A.C., Flor-Henry P., Joshi P., Powles A.C.P., Sherkey J.A., van de Sande M. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment guidelines: a consensus document. Journal of Chronic Fatigue Syndrome 2003, 11(1):7-115.
5. Carruthers B.M., van de Sande M.I., de Meirleir K.L., Klimas N.G., Broderick G., Mitchell T., Staines D., Powles A.C.P., Speight N., Vallings R., Bateman L., Baumgarten-Austrheim B., Bell D.S., Carlo-Stella N., Chia J., Darragh A., Jo D., Lewis D., Light A.R., Marshall-Gradisbik S., Mena S., Mikovits I., Miwa J.A., Murovska K., Pall M., Stevens M.L. Myalgic encephalomyelitis: international consensus criteria. Journal of Internal Medicine 2011, 270(4):327-338.
6. Cavadini G., Petrzilka S., Kohler P., Jud C., Tobler I., Birchler T., Fontana A. TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proceedings of the National Academy of Sciences in the USA 2007, 104(31):12843-12848.
7. Cockshell S.J., Mathias J.L. Cognitive functioning in chronic fatigue syndrome: a meta-analysis. Psychological Medicine 2010, 40(8):1253-1267.
8. Crowley N., Nelson M., Stovin S. Epidemiological aspects of an outbreak of encephalomyelitis at the Royal Free Hospital, London, in the summer of 1955. The Journal of Hygiene (London) 1957, 55(1):102-122.
9. Derde M.P., Massart D.L. Extraction of information from large data sets by pattern recognition. Fresenius Z. Analytical Chemistry 1982, 313:484-495.
10. Dowsett, E.G., Goudsmit, E., Macintyre, A., Shepherd, C.B., 1994. London criteria for M.E. Report from The National Task Force on Chronic Fatigue Syndrome (CFS), Post Viral Fatigue Syndrome (PVFS), Myalgic Encephalomyelitis (ME). Westcare, 1994. pp. 96-98.
11. Fukuda K., Straus S.E., Hickie I., Sharpe M., Dobbins J.G., Komaroff A.L. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of Internal Medicine 1994, 121(12):953-959. http://www.ncf-net.org/patents/pdf/Fukuda_Definition.pdf.
12. Gilliam A.G. Epidemiological study on an epidemic, diagnosed as poliomyelitis, occurring among the personnel of Los Angeles County General Hospital during the summer of 1934. United States Treasury Department Public Health Service Public Health Bulletin 1938, 240:1-90.
13. Hermann G.E., Rogers R.C. TNFalpha: a trigger of autonomic dysfunction. Neuroscientist 2008, 14(1):53-67.
14. Holmes G.P., Kaplan J.E., Gantz N.M., Komaroff A.L., Schonberger L.B., Straus S.E., Jones J.F., Dubois R.E., Cunningham-Rundles C., Pahwa S. Chronic fatigue syndrome: a working case definition. Annals of Internal Medicine 1988, 108:387-389.
15. Hurwitz B.E., Coryell V.T., Parker M., Martin P., Laperriere A., Klimas N.G., Sfakianakis G.N., Bilsker M.S. Chronic fatigue syndrome: illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function. Clinical Science (Lond) 2009, 118(2):125-135.
16. Jiang Y., Deacon R., Anthony D.C., Campbell S.J. Inhibition of peripheral TNF can block the malaise associated with CNS inflammatory diseases. Neurobiological Disorders 2008, 32(1):125-132.
17. Lane R.J., Barrett M.C., Taylor D.J., Kemp G.J., Lodi R. Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle. Neuromuscular Disorders 1998, 8(3-4):204-209.
18. Maes M. Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms. Current Opinion in Psychiatry 2009, 22(1):75-83.
19. Maes M., Twisk F.N. Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways. BMC Medicine 2010, 8:35. (highly accessed paper).
20. Maes M., Cosyns P., Maes L., D'Hondt P., Schotte C. Clinical subtypes of unipolar depression: part I. A validation of the vital and nonvital clusters. Psychiatry Research 1990, 34(1):29-41.
21. Maes M., Schotte C., Maes L., Cosyns P. Clinical subtypes of unipolar depression: part II. Quantitative and qualitative clinical differences between the vital and nonvital depression groups. Psychiatry Research 1990, 34(1):43-57.
22. Maes M., Maes L., Schotte C., Vandewoude M., Martin M., D'Hondt P., Blockx P., Scharpé S., Cosyns P. Clinical subtypes of unipolar depression: part III. Quantitative differences in various biological markers between the cluster-analytically generated nonvital and vital depression classes. Psychiatry Research 1990, 34(1):59-75.
23. Maes M., Delmeire L., Schotte C., Janca A., Creten T., Mylle J., Struyf A., Pison G., Rousseeuw P.J. Epidemiologic and phenomenological aspects of post-traumatic stress disorder: DSM-III-R diagnosis and diagnostic criteria not validated. Psychiatry Research 1998, 81(2):179-193.
24. Maes M., Mihaylova I., Leunis J.C. Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins. Neuro Endocrinology Letters 2006, 27(5):615-621.
25. Maes M., Mihaylova I., Leunis J.C. Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. Journal of Affective Disorders 2007, 99(1-3):237-240.
26. Maes M., Twisk F.N., Kubera M., Ringel K. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Increased interleukin-1, tumor necrosis factor-αa, PMN-elastase, lysozyme and neopterin. Journal of Affective Disorders 2011, 2011 October 3. [Epub ahead of print] PubMed PMID: 21975140.
27. Massart L., Kaufman L. Nonhierarchical clustering methods. The Interpretation of Analytical Chemical Data by the Use of Cluster Analysis 1983, 101-138. John Wiley and Sons, New York. P.J. Elving, J.D. Winefordner (Eds.).
28. Nacul L.C., Lacerda E.M., Pheby D., Campion P., Molokhia M., Fayyaz S., Leite J.C., Poland F., Howe A., Drachler M.L. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care. BMC Medicine 2011, 9:91. 10.1186/1741-7015-9-91.
29. Anon Epidemic myalgic encephalomyelitis. British Medical Journal 1978, 1(6125):1436-1437.
30. Peckerman A., LaManca J.J., Dahl K.A., Chemitiganti R., Qureishi B., Natelson B.H. Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome. American Journal of Medical Sciences 2003, 326(2):55-60.
31. Ramsay A. Myalgic Encephalomyelitis and Postviral Fatigue States: The Saga of Royal Free Disease 1988, Gower Medical Publications for the Myalgic Encephalomyelitis Association, Londen. 2nd ed.
32. Sheng W.S., Hu S., Lamkin A., Peterson P.K., Chao C.C. Susceptibility to immunologically mediated fatigue in C57BL/6 versus Balb/c mice. Clinical Immunology and Immunopathology 1996, 81(2):161-167.
33. Sheng W.S., Hu S., Ding J.M., Chao C.C., Peterson P.K. Cytokine expression in the mouse brain in response to immune activation by Corynebacterium parvum. Clinical and Diagnostic Laboratory Immunology 2001, 8(2):446-448.
34. Strickland P.S., Levine P.H., Peterson D.L., O'Brien K., Fears T. Neuromyasthenia and chronic fatigue syndrome (CFS) in Northern Nevada/California: a ten-year follow-up of an outbreak. Journal of Chronic Fatigue Syndrome 2001, 9(3-4):3-14.
35. Twisk F.N., Maes M. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME)/ chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS. Neuro Endocrinology Letters 2009, 30(3):284-299.
36. Vermeulen R.C.W., Kurk R.M., Visser F.C., Sluiter W., Scholte H.R. Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity. Journal of Translational Medicine 2010, 8:93.
37. Wessely S. Chronic fatigue syndrome. Summary of a report of a joint committee of the Royal Colleges of Physicians, Psychiatrists and General Practitioners. Journal of the Royal College of Physicians of London 1996, 30(6):497-504.
38. WHO, 1967. ICD-8. International Classification of Diseases, Eighth Revision, I (code 323), p. 158.
39. WHO, 1992. ICD-10. International Classification of Diseases, Tenth Revision, G93.3.
40. Zachrisson O., Regland B., Jahreskog M., Kron M., Gottfries C.G. A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). Journal of Psychosomatic Research 2002, 52(6):501-509.